A detailed history of Cyndeo Wealth Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Cyndeo Wealth Partners, LLC holds 3,253 shares of NVO stock, worth $374,355. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,253
Previous 3,705 12.2%
Holding current value
$374,355
Previous $475,000 2.32%
% of portfolio
0.04%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$122.71 - $146.91 $55,464 - $66,403
-452 Reduced 12.2%
3,253 $464,000
Q1 2024

Apr 16, 2024

BUY
$102.11 - $135.92 $1,940 - $2,582
19 Added 0.52%
3,705 $475,000
Q4 2023

Jan 12, 2024

BUY
$87.78 - $105.45 $1,843 - $2,214
21 Added 0.57%
3,686 $381,000
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $169,784 - $372,541
1,867 Added 103.84%
3,665 $333,000
Q2 2023

Jul 27, 2023

SELL
$155.98 - $172.65 $3,587 - $3,970
-23 Reduced 1.26%
1,798 $290,000
Q4 2022

Jan 25, 2023

BUY
$102.55 - $135.33 $186,743 - $246,435
1,821 New
1,821 $0

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $260B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cyndeo Wealth Partners, LLC Portfolio

Follow Cyndeo Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cyndeo Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cyndeo Wealth Partners, LLC with notifications on news.